<DOC>
	<DOCNO>NCT01593605</DOCNO>
	<brief_summary>The study evaluate effect resveratrol/leucine resveratrol/HMB ability control glucose level person without diabetes impair fast glucose . Secondary assessment examine effect nutritional supplement versus placebo inflammation , fast lipid , HbA1C , fructosamine , long term metabolic marker risk diabetes .</brief_summary>
	<brief_title>Resveratrol-Leucine Metabolite Synergy Pre-diabetes</brief_title>
	<detailed_description>This 28-day randomized control trial effect nutraceutical preparation glycemic control non-diabetic individual impair glucose tolerance ( IGT ) . IGT define American Diabetes Association criterion , outline list inclusion exclusion criterion ( copy attach ) . There two active treatment arm placebo arm ( 3 arm total , n=12 complete subject per arm ) . Following screen inclusion/exclusion criterion obtain informed consent , subject enrol study provide instruction maintain usual dietary pattern physical activity level . If recent physical examination medical history available ; H &amp; P conduct record enrolled subject . Subjects instruct follow 12-hour fast start day -1 , morning day 0 fasting blood drawn analysis indicate supplement distribute . Supplements distribute use blind protocol variable , know pill allotment order ass compliance via standard pill count . Pill bottle unused supplement return seven day interval , new supply distribute time . Fasting blood sample obtain day 0 , 7 , 14 28 . Samples day analyze glucose insulin . Samples day 0 , 14 28 also analyzed fructosamine , C-peptide , glucagon F2-isoprostanes . A75 g oral glucose tolerance test administer day 0 28 .</detailed_description>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>Impaired fast glucose define American Diabetes Association criterion : fasting plasma glucose level 5.6 mmol/L ( 100 mg/dL ) 6.9 mmol/L ( 125 mg/dL ) Body mass index ( BMI ) 2534.9 Age 18 aboveâ€¢ Weight stable : 1 kg weight gain loss past 12 week Fasting glucose &gt; 126 &lt; 99 mg/dL BMI &lt; 25 &gt; 35 Current/previous diagnosis diabetes History eat disorder presence active gastrointestinal disorder malabsorption syndrome Pregnancy lactation Anemia , define hemoglobin level less 10g/dl . Use obesity pharmacotherapeutic agent within last 6 month Use overthecounter antiobesity agent ( e.g . contain phenylpropylamine , ephedrine and/or caffeine ) within last 3 month Chronic use antiinflammatory agent within last four week Use antioxidant supplement within last four week include selenium , vitamin E , vitamin C and/or carotenoid Use supplement contain study compound within past four week Recent ( current past 12 week ) use psychotropic medication Recent ( past four week ) initiation change exercise program Recent ( past twelve week ) initiation hormone replacement therapy change HRT regimen Recent ( past twelve week ) initiation hormonal birth control change hormonal birth control regimen Recent ( past 12weeks ) history tobacco use Any Condition P.I . considers adverse participant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Impaired glucose tolerance , pre-diabetes , glycemic control ,</keyword>
	<keyword>supplement</keyword>
</DOC>